Enhancing DNA-based therapies further ahead

A groundbreaking platform that extends the reach of genetic treatments by combining unprecedented DNA optimisation with non-viral delivery.

We’re determined to provide the next generation of DNA-based therapies.

We have developed a purpose-built next generation platform to expand the reach of current gene therapies and provide hope to patients suffering from rare genetic diseases.

Platform for Next Generation DNA-based Therapies.

By combining our pioneering oDNA™ with exclusive innovative Non-Viral vector delivery, we are progressing re-dosable gene therapies with drug titration capabilities and targeted biodistribution, whatever the size of the gene involved.

Non-viral
DNA-based
medicine

Platform for Next Generation DNA-based Therapies.

By combining our pioneering oDNA™ with exclusive innovative Non-Viral vector delivery, we are progressing re-dosable gene therapies with drug titration capabilities and targeted biodistribution, whatever the size of the gene involved.

Enhancing DNA based therapies further ahead

01.
Redosing
Redosing ability to provide lifelong control of the disease

02.
Drug titration
Drug titration to deliver personalized treatment response

03.
Targeted delivery
Targeted biodistribution to organs and specific cell types

04.
No size limitation
No transgene size limitation to adress a wide range of diseases

05.
oDNA™ modulation
oDNA™ versatile modulation of transgene properties, beyond regulatory cassette

06.
Focused constructs
oDNA™ free of antibiotic resistance and any bacterial sequences

We develop the next generation of non-viral gene therapies to provide all patients with a personalized and long-term control of their genetic disease, while exploring additional applications of our platform in more prevalent indications.